[ad_1]
The ECD was specifically designed to detect cavities on the chewing surfaces of molars and premolars. These tooth surfaces are most affected by decay and are a major diagnostic challenge for dentists. The ECD was developed, patented and clinically tested at Stony Brook University School of Dental Medicine and exclusively licensed to Ortek. The ECD demonstrated 100% sensitivity and 93% specificity in a published peer-reviewed clinical study. The ECD is fast, easy to use, and does not cause pain or discomfort for the patient.
Using the ECD, a dental professional gently places a stainless steel tip in the grooves of molars and premolars. By measuring the conductivity of enamel, the ECD immediately displays a quantitative digital cavities score, allowing dental professionals to accurately and quickly recommend appropriate treatment options, including minimally invasive procedures.
“The Ortek-ECD is a vital instrument to aid in the diagnosis of cavities that might otherwise go undetected,” said Howard Glazer, DDS FAGD, and Past President of the Academy of General Dentistry. “It allows for early intervention and minimizes the loss of tooth structure.”
“Globally, it is estimated that 2.3 billion people suffer from cavities of permanent teeth and approximately ninety percent of Americans over 20 have had cavities at some point in their lives,” said Mitchell Goldberg, President of Ortek Therapeutics, Inc. “The ECD is a major technological innovation that will significantly improve patient outcomes by helping avoid the unwanted consequences of more advanced tooth decay.”
The Technology
Powered by a 9 volt battery, the patented ECD is a small portable device that has a base unit with a digital display, and a handpiece with a novel stainless steel tip that touches the bottom of pit and fissures, the grooves of molars and premolars. It’s been estimated that 70%-90% of tooth decay occurs in these vulnerable sites.
A tooth is considered cavitated if demineralization breaches the enamel and exposes the underlying dentin, which contains fluid filled tubules. When cavitation occurs, hydrostatic pressure will allow minuscule amounts of conductive dentinal fluid to enter the breached enamel site, causing the ECD to complete an electrical circuit, thereby detecting a cavity.
As this demineralization or cavity activity progresses, more dentinal fluid enters the breached site. The more fluid detected results in a higher current and an increasing digital cavity score that is digitally displayed from 01-100. When the enamel at the bottom of a pit or fissure is intact, no current can flow and the ECD will display a zero score. This indicates a healthy tooth or a non-cavitated lesion.
To learn more about the Ortek-ECD, visit www.ortekecd.com
About Ortek
Ortek Therapeutics, Inc. is a global leader in developing and commercializing cutting edge oral care technologies. Through its long-standing strategic alliance with the Research Foundation for the State University of New York, Ortek has developed major scientific breakthroughs including the revolutionary arginine bicarbonate, calcium carbonate technology for cavity prevention and treatments for dentinal sensitivity. Additionally, this partnership has led to FDA clearance and commercialization for an advanced electronic cavity detection device – the Ortek-ECD.
SOURCE Ortek Therapeutics, Inc.
Related Links
[ad_2]
Source link